Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Oliver & Co who wrote (2896)	11/20/1997 1:43:00 PM
From: wayne fishback	Read Replies (2) of 6136

Dr Oliver: I recently posted the extreme improvement my son experienced after switching from Cryx to Viracept. While my son's situation is anecdotal my research indicates comparable results for most people. Could you explain why you continue to prescribe Cryx albeit "2nd choice". I wonder if your reasoning explains why Cryx continues to be the leading P.I. although gradually losing market share. If not any thoughts on Viracept's market position a year or two from now. Wayne

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next